Page last updated: 2024-11-06

1,6-hexanediol dimethacrylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

1,6-hexanediol dimethacrylate (HDDA) is a bifunctional monomer widely used in the synthesis of polymers, particularly in the fabrication of dental materials, coatings, and adhesives. HDDA is typically synthesized through the reaction of 1,6-hexanediol with methacrylic acid in the presence of a catalyst. Its unique properties, including its high reactivity and ability to form cross-linked networks, make it a valuable component in dental composites. The cross-linking ability of HDDA contributes to the strength and durability of these materials, making them suitable for fillings, crowns, and other dental applications. Studies on HDDA focus on understanding its polymerization behavior, optimizing its use in dental formulations, and assessing its biocompatibility and potential toxicity. The compound's effects on dental health, including its potential to cause irritation or allergic reactions, are subjects of ongoing research.'

Cross-References

ID SourceID
PubMed CID81080
CHEMBL ID3183323
SCHEMBL ID24216
MeSH IDM0240224

Synonyms (50)

Synonym
rao49190jv ,
2-propenoic acid, 2-methyl-, 1,1'-(1,6-hexanediyl) ester
unii-rao49190jv
1,6-hexanediol dimethacrylate, contains 100 ppm hydroquinone as inhibitor, >=90%
1,6-hexanediol dimethacrylate
ccris 7049
1,6-hexanediyl bismethacrylate
einecs 229-551-7
2-propenoic acid, 2-methyl-, 1,6-hexanediyl ester
6606-59-3
6-(2-methylprop-2-enoyloxy)hexyl 2-methylprop-2-enoate
H1369
1,6-bis(methacryloyloxy)hexane
NCGC00255742-01
cas-6606-59-3
dtxcid7024455
tox21_302093
dtxsid9044455 ,
AKOS015902853
BP-30168
SCHEMBL24216
hexane-1,6-diyl bis(2-methylacrylate)
hexamethylene dimethacrylate
W-104775
1,6-hexyleneglycol dimethacrylate
hddma
hexamethylene methacrylate
methacrylic acid, hexamethylene ester
1,6-hexamethylenediol dimethacrylate
1,6-hexamethylene dimethacrylate
hexamethylene glycol dimethacrylate
1,6-hexanediyl dimethacrylate
1,6-hexanediol, dimethacrylate
1,6-hexamethylene glycol dimethacrylate
hexamethylene glycol methacrylate
CHEMBL3183323
mfcd00015425
6-[(2-methylprop-2-enoyl)oxy]hexyl 2-methylprop-2-enoate
AS-59874
1,6-hexanediol dimethacrylate, 95%, contains 100ppm mehq as stabilizer
1,6-hexanediol dimethacrylate (stabilized with mehq)
FT-0734188
1,6-hexanedioldimethacrylate
1,6-hexanediol dimethacrylate,min 98%
1,6-hexanediol dimethacrylate(8 cp(23 degrees c))
Q27288026
2-propenoic acid, 2-methyl-, 1,6-hexanediyl ester; 1,6-hexanediol dimethacrylate
A867535
hexane-1,6-diylbis(2-methylacrylate)
F71251
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency1.52600.000221.22318,912.5098AID743035; AID743063
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency0.96890.001723.839378.1014AID743083
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (29.17)18.2507
2000's8 (33.33)29.6817
2010's9 (37.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.47 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index50.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.85%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]